The c.512G>A variant in PAH is a missense variant predicted to cause substitution of glycine by glutamic acid at amino acid 171 (p.Gly171Glu). At least one patient with this variant displayed plasma phenylalanine concentration persistently above 120umol/L (2mg/dL) AND sequencing of genes in the BH4 cofactor metabolism pathway excluded a defect of BH4 cofactor metabolism, which is highly specific for PAH deficiency (PP4_Moderate, PMID: 26575882, 31332730). This variant is absent from gnomAD v4.1.0 (PM2_Supporting). The computational predictor REVEL gives a score of 0.926, which is above the threshold of 0.773 but below 0.932, evidence that correlates with moderate impact to PAH function (PP3_Moderate). Another missense variant c.512G>C (p.Gly171Ala) [ClinVar Variation ID: 102717] in the same codon has been classified as likely pathogenic for PAH deficiency by the ClinGen PAH Variant Curation Expert Panel (PM5_Supporting). In summary, this variant meets criteria to be classified as likely pathogenic for autosomal recessive PAH deficiency based on the ACMG/AMP criteria applied, as specified by the ClinGen PAH Variant Curation Expert Panel: PP4_moderate, PM2_supporting, PP3_moderate, PM5_supporting (PAH VCEP specifications version 2.0.0; approved July 16, 2024).